OOIR: Observatory of International Research

Papers

(The TQCC of JACC-Cardiovascular Interventions is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Drug-Coated Balloons for Coronary Artery Disease	214
3-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation	155
Alignment of Transcatheter Aortic-Valve Neo-Commissures (ALIGN TAVR)	140
Indigo Aspiration System for Treatment of Pulmonary Embolism	140
5-Year Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves	125
Incidence, Predictors, and Implications of Permanent Pacemaker Requirement After Transcatheter Aortic Valve Replacement	122
Coronary Cannulation After Transcatheter Aortic Valve Replacement	118
Transfemoral Transcatheter Tricuspid Valve Replacement With the EVOQUE System	115
ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION)	109
Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease	102
Distal Radial Artery Approach to Prevent Radial Artery Occlusion Trial	94
Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy	90
Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease	87
Valve-in-Valve Transcatheter Aortic Valve Replacement Versus Redo Surgical Aortic Valve Replacement	85
Transcatheter Aortic Valve Replacement in Bicuspid Versus Tricuspid Aortic Valves From the STS/ACC TVT Registry	83
Early Multinational Experience of Transcatheter Tricuspid Valve Replacement for Treating Severe Tricuspid Regurgitation	81
Principles of Intravascular Lithotripsy for Calcific Plaque Modification	80
Clinical Outcomes Following Coronary Bifurcation PCI Techniques	80
Coronary Calcification and Long-Term Outcomes According to Drug-Eluting Stent Generation	79
Reoperation After Transcatheter Aortic Valve Replacement	79
Randomized Trial Comparing Standard Versus Ultrasound-Assisted Thrombolysis for Submassive Pulmonary Embolism	77
Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Bicuspid Aortic Valve Stenosis	76
Randomized Comparison of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation in Prohibitive Surgical Risk Patients	73
Patient-Specific Implantation Technique to Obtain Neo-Commissural Alignment With Self-Expanding Transcatheter Aortic Valves	72
Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement	72

Cardiopulmonary Hemodynamic Profile Predicts Mortality After Transcatheter Tricuspid Valve Repair in Chronic Heart Failure	72
Long-Term Outcomes of Coronary Stenting With and Without Use of Intravascular Ultrasound	71
Impact of Left Ventricular Outflow Tract Calcification on Procedural Outcomes After Transcatheter Aortic Valve Replacement	70
COAPT-Like Profile Predicts Long-Term Outcomes in Patients With Secondary Mitral Regurgitation Undergoing MitraClip Implantation	70
Suture- or Plug-Based Large-Bore Arteriotomy Closure	70
Aspirin-Free Prasugrel Monotherapy Following Coronary Artery Stenting in Patients With Stable CAD	69
Intravascular Lithotripsy for Treatment of Calcified Coronary Lesions	69
Surgical Explantation After TAVR Failure	68
Short Duration of DAPT Versus De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes	68
Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization	67
Clinical Outcomes Associated With Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation	67
Permanent Pacemaker Reduction Using Cusp-Overlapping Projection in TAVR	65
Intravascular Lithotripsy for Peripheral Artery Calcification	65
Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic	64
Transcatheter Edge-to-Edge Mitral Valve Repair With the MitraClip G4 System	64
Risk of Coronary Obstruction Due to Sinus Sequestration in Redo Transcatheter Aortic Valve Replacement	64
Arterial Lactate in Cardiogenic Shock	63
Coronary Access After TAVR-in-TAVR as Evaluated by Multidetector Computed Tomography	63
The Impact of Coronary Physiology on Contemporary Clinical Decision Making	62
Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Replacement	62
Racial, Ethnic, and Sex Disparities in Patients With STEMI and Cardiogenic Shock	62
Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients With Atrial Fibrillation After TAVR	61
1-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study	61
Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation	60
Distal or Traditional Transradial Access Site for Coronary Procedures	58
3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation	57
6-Month Outcomes of the TricValve System in Patients With Tricuspid Regurgitation	56
Transcatheter Mitral Valve Replacement	56
Transcatheter Mitral Valve Repair in Cardiogenic Shock and Mitral Regurgitation	56
Early Feasibility Study of Cardioband Tricuspid System for Functional Tricuspid Regurgitation	55
Clinical Characteristics and Outcomes of STEMI Patients With Cardiogenic Shock and Cardiac Arrest	55
Superior Vena Cava Syndrome	54
Alterra Adaptive Prestent and SAPIEN 3 THV for Congenital Pulmonic Valve Dysfunction	54
Randomized Evaluation of TriGuard 3 Cerebral Embolic Protection After Transcatheter Aortic Valve Replacement	54
Preventing Coronary Obstruction During Transcatheter Aortic Valve Replacement	54
Prosthesis-Patient Mismatch After Aortic Valve Replacement in the PARTNER 2 Trial and Registry	53
Contemporary Issues in Chronic Total Occlusion Percutaneous Coronary Intervention	53
Value of Echocardiographic Right Ventricular and Pulmonary Pressure Assessment in Predicting Transcatheter Tricuspid Repair Outcome	52
Right Ventricular Contraction Patterns in Patients Undergoing Transcatheter Tricuspid Valve Repair for Severe Tricuspid Regurgitation	52
Distal Versus Conventional Radial Access for Coronary Angiography and Intervention	51
Transcatheter Aortic Valve Replacement With Balloon-Expandable Valves	51
Prognostic Impact of Race in Patients Undergoing PCI	49
Prospective Study of TMVR Using Balloon-Expandable Aortic Transcatheter Valves in MAC	49
Functional Coronary Angiography–Derived Index of Microcirculatory Resistance in Patients With ST-Segment Elevation Myocardial Infarction	48
Predicting Periprocedural Complications in Chronic Total Occlusion Percutaneous Coronary Intervention	48
Procedural and Short-Term Results With the New Watchman FLX Left Atrial Appendage Occlusion Device	47
1-Month Dual-Antiplatelet Therapy Followed by Aspirin Monotherapy After Polymer-Free Drug-Coated Stent Implantation	47
Long-Term Follow-Up in Patients With Stable Angina and Unobstructed Coronary Arteries Undergoing Intracoronary Acetylcholine Testing	47
Short-Term Clinical Outcomes of Transcatheter Tricuspid Valve Repair With the Third-Generation MitraClip XTR System	46
The Utility of Rapid Atrial Pacing Immediately Post-TAVR to Predict the Need for Pacemaker Implantation	46

12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal Denervation	46
30-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement	45
Transcatheter Mitral Valve Replacement With the Transseptal EVOQUE System	45
First-in-Man Experience of Transcatheter Tricuspid Valve Replacement With LuX-Valve in High-Risk Tricuspid Regurgitation Patients	45
Resuscitation Using ECPR During In-Hospital Cardiac Arrest (RESCUE-IHCA) Mortality Prediction Score and External Validation	45
1-Year Outcomes of Fluoropolymer-Based Drug-Eluting Stent in Femoropopliteal Practice	45
Half-Dose Direct Oral Anticoagulation Versus Standard Antithrombotic Therapy After Left Atrial Appendage Occlusion	44
Peridevice Leak Following Amplatzer Left Atrial Appendage Occlusion	43
Acute Coronary Tree Thrombosis After Vaccination for COVID-19	43
Double S-Curve Versus Cusp-Overlap Technique	43
Coronary Artery Fistulas	43
Impact of Massive or Torrential Tricuspid Regurgitation in Patients Undergoing Transcatheter Tricuspid Valve Intervention	43
Comparison of Doppler Flow Velocity and Thermodilution Derived Indexes of Coronary Physiology	42
The Impact of Intravascular Ultrasound on Femoropopliteal Artery Endovascular Interventions	42
Outcomes Following Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement	42
Predictors and Clinical Impact of Prosthesis-Patient Mismatch After Self-Expandable TAVR in Small Annuli	42
Transcatheter Tricuspid Valve Replacement With the EVOQUE System	42
Mechanical Circulatory Support as a Bridge to Definitive Treatment in Post-Infarction Ventricular Septal Rupture	41
Prospective Evaluation of Transseptal TMVR for Failed Surgical Bioprostheses	41
Impact of Moderate Aortic Stenosis on Long-Term Clinical Outcomes	41
2-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study	41
Distal Radial Access	41
Outcomes of Prosthesis-Patient Mismatch Following Supra-Annular Transcatheter Aortic Valve Replacement	40
Transcatheter Aortic Valve Replacement in Patients With Multivalvular Heart Disease	40
Impact of Residual Mitral Regurgitation on Survival After Transcatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation	40
Frequency and Impact of Bleeding on Outcome in Patients With Cardiogenic Shock	40
Right Ventricular–Pulmonary Arterial Coupling in Patients With HF Secondary MR	39
Frailty and Bleeding in Older Adults Undergoing TAVR or SAVR	38
Improved 3-Year Cardiac Survival After IVUS–Guided Long DES Implantation	38
Outcomes After Transcatheter Aortic Valve Replacement in Bicuspid Versus Tricuspid Anatomy	38
Ischemic Stroke With Cerebral Protection System During Transcatheter Aortic Valve Replacement	37
Impact of Intravascular Ultrasound on Long-Term Clinical Outcomes in Patients With Acute Myocardial Infarction	37
Spontaneous Coronary Artery Dissection	37
Balloon-Expandable Valve for Treatment of Evolut Valve Failure	36
Incidence, Predictors, and Outcomes of Endocarditis After Transcatheter Aortic Valve Replacement in the United States	36
Defining Percutaneous Coronary Intervention Complexity and Risk	36
1-Year Results From the RANGER II SFA Randomized Trial of the Ranger Drug-Coated Balloon	36
Randomized Comparison Between Radial and Femoral Large-Bore Access for Complex Percutaneous Coronary Intervention	35
Prospective Evaluation of TMVR for Failed Surgical Annuloplasty Rings	35
Association Between Timing of Extracorporeal Membrane Oxygenation and Clinical Outcomes in Refractory Cardiogenic Shock	35
Evaluation and Management of Nonculprit Lesions in STEMI	35
2-Year Outcomes of the Eluvia Drug-Eluting Stent for the Treatment of Complex Femoropopliteal Lesions	35
Role of Post-Stent Physiological Assessment in a Risk Prediction Model After Coronary Stent Implantation	35
Randomized Controlled Trial of Acotec Drug-Eluting Balloon Versus Plain Balloon for Below-the-Knee Angioplasty	35
Use of Atherectomy During Index Peripheral Vascular Interventions	35
Effect of Mitral Valve Gradient After MitraClip on Outcomes in Secondary Mitral Regurgitation	35
Intravascular Healing Is Not Affected by Approaches in Contemporary CTO PCI	34
Spontaneous Coronary Artery Dissection in a Patient With COVID-19	34
Effect of Transcatheter Aortic Valve Replacement on Concomitant Mitral Regurgitation and Its Impact on Mortality	34
1-Year Outcomes of Blinded Physiological Assessment of Residual Ischemia After Successful PCI	34
Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI	34
Basics of Coronary Thermodilution	34
Percutaneous Atriotomy for Levoatrial–to–Coronary Sinus Shunting in Symptomatic Heart Failure	33
Stent Expansion Indexes to Predict Clinical Outcomes	33
TAVR Patients Requiring Anticoagulation	33
Long-Term Follow-Up of Hypoattenuated Leaflet Thickening After Transcatheter Aortic Valve Replacement	33
The Use and Outcomes of Cerebral Protection Devices for Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement in Clinical Practice	33
Long-Term Clinical Impact of Contrast-Associated Acute Kidney Injury Following PCI	33
Contemporary Outcomes Following Transcatheter Edge-to-Edge Repair	33
Antithrombotic Therapy After Transcatheter Aortic Valve Replacement	32
Percutaneous Coronary Intervention for Chronic Total Occlusion—The Michigan Experience	32
NYHA Functional Classification and Outcomes After Transcatheter Mitral Valve Repair in Heart Failure	32
Transcatheter Versus Surgical Aortic Valve Replacement in Young, Low-Risk Patients With Severe Aortic Stenosis	31
Safety of Revascularization Deferral of Left Main Stenosis Based on Instantaneous Wave-Free Ratio Evaluation	31
Balloon-Assisted BASILICA to Facilitate Redo TAVR	31
Revascularization Deferral of Nonculprit Stenoses on the Basis of Fractional Flow Reserve	31
Fractional Flow Reserve–Based Coronary Artery Bypass Surgery	31
Safety and Efficacy of Protamine Administration for Prevention of Bleeding Complications in Patients Undergoing TAVR	30
Acetylcholine Rechallenge	30
Transcatheter Treatment of Residual Significant Mitral Regurgitation Following TAVR	30
Age-Related Outcomes After Transcatheter Aortic Valve Replacement	30
Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease	30
The PARTNER 3 Bicuspid Registry for Transcatheter Aortic Valve Replacement in Low-Surgical-Risk Patients	30
Leaflet Configuration and Residual Tricuspid Regurgitation After Transcatheter Edge-to-Edge Tricuspid Repair	30
Unplanned Percutaneous Coronary Revascularization After TAVR	30
Electrosurgical Detachment of MitraClips From the Anterior Mitral Leaflet Prior to Transcatheter Mitral Valve Implantation	29
Prediction of Death or HF Hospitalization in Patients With Severe FMR	29
Procedural Characteristics and Late Outcomes of Percutaneous Coronary Intervention in the Workup Pre-TAVR	29
Renal Denervation for Hypertension	29
Optimal Fluoroscopic Projections of Coronary Ostia and Bifurcations Defined by Computed Tomographic Coronary Angiography	29

Propensity-Matched 1-Year Outcomes Following Transcatheter Aortic Valve Replacement in Low-Risk Bicuspid and Tricuspid Patients	29
Impact of Right Ventricle-Pulmonary Artery Coupling on Clinical Outcomes in the PARTNER 3 Trial	29
Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves	29
Treatment of Coronary De Novo Lesions by a Sirolimus- or Paclitaxel-Coated Balloon	28
Functional and Echocardiographic Improvement After Transcatheter Repair for Tricuspid Regurgitation	28
FFR-Guided PCI Optimization Directed by High-Definition IVUS Versus Standard of Care	28
Rationale, Definitions, Techniques, and Outcomes of Commissural Alignment in TAVR	28
Feasibility and Safety of Same-Day Discharge Following Transfemoral Transcatheter Aortic Valve Replacement	28
Explant vs Redo-TAVR After Transcatheter Valve Failure	28
Shifting Trends in Timing of Pacemaker Implantation After Transcatheter Aortic Valve Replacement	28
Long-Term Outcomes of Patients With Elevated Mitral Valve Pressure Gradient After Mitral Valve Edge-to-Edge Repair	28
Left Ventricular End-Diastolic Pressure Versus Urine Flow Rate–Guided Hydration in Preventing Contrast-Associated Acute Kidney Injury	28
Demographics, Procedural Characteristics, and Clinical Outcomes When Cardiogenic Shock Precedes TAVR in the United States	28
Optimal Stenting Technique for Complex Coronary Lesions	28
Titanium-Nitride-Oxide–Coated Versus Everolimus-Eluting Stents in Acute Coronary Syndrome	27
Automated Algorithm Using Pre-Intervention Fractional Flow Reserve Pullback Curve to Predict Post-Intervention Physiological Results	27
Transcatheter Aortic Valve Replacement With the Latest-Iteration Self-Expanding or Balloon-Expandable Valves	27
Implications of Periprocedural Myocardial Biomarker Elevations and Commonly Used MI Definitions After Left Main PCI	27
Safety Profile of an Intra-Annular Self-Expanding Transcatheter Aortic Valve and Next-Generation Low-Profile Delivery System	27
Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR	27
Distal vs Conventional Radial Access for Coronary Angiography and/or Intervention	27
Prognostic Links Between OCT-Delineated Coronary Morphologies and Coronary Functional Abnormalities in Patients With INOCA	27
Prediction of Coronary Stent Underexpansion by Pre-Procedural Intravascular Ultrasound–Based Deep Learning	26
Mitral Valve Surgery After Transcatheter Edge-to-Edge Repair	26
EROSION III	26
Nationally Representative Repeat Transcatheter Aortic Valve Replacement Outcomes	26
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndromes and Diabetes Mellitus	26
Transfemoral Transcatheter Tricuspid Valve Replacement	26
First-in-Human Transcatheter Tricuspid Valve Repair	26
Clinical Impact of Standardized TAVR Technique and Care Pathway	26
Differential Improvement in Angina and Health-Related Quality of Life After PCI in Focal and Diffuse Coronary Artery Disease	26
Physiological Distribution and Local Severity of Coronary Artery Disease and Outcomes After Percutaneous Coronary Intervention	25
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI	25
Prognostic Value of Increased Mitral Valve Gradient After Transcatheter Edge-to-Edge Repair for Primary Mitral Regurgitation	25
Cancer Patients Have a Higher Risk of Thrombotic and Ischemic Events After Percutaneous Coronary Intervention	25
Multicenter Experience With the Transcatheter Leaflet Repair System for Symptomatic Tricuspid Regurgitation	25
5-Year Outcomes From the Harmony Native Outflow Tract Early Feasibility Study	25
Sex Differences in Management and Outcomes of Acute Myocardial Infarction Patients Presenting With Cardiogenic Shock	25
Real-World Outcomes of Fourth-Generation Mitral Transcatheter Repair	25
Impact of Surgical and Transcatheter Aortic Valve Replacement in Low-Gradient Aortic Stenosis	24
Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years	24
Randomized Controlled Trial of Conventional Versus MicroNet-Covered Stent in Carotid Artery Revascularization	24
Leaflet and Neoskirt Height in Transcatheter Heart Valves	24
Development and Validation of a Practical Model to Identify Patients at Risk of Bleeding After TAVR	24
Access-Site Crossover in Patients With Acute Coronary Syndrome Undergoing Invasive Management	24
Comparisons of Nonhyperemic Pressure Ratios	24
Evaluation of Mortality Following Paclitaxel Drug-Coated Balloon Angioplasty of Femoropopliteal Lesions in the Real World	24
Management and Outcomes of Transvenous Pacing Leads in Patients Undergoing Transcatheter Tricuspid Valve Replacement	24
Commissural Versus Coronary Optimized Alignment During Transcatheter Aortic Valve Replacement	24
Transcaval Versus Transaxillary TAVR in Contemporary Practice	24
Multivessel Versus Culprit-Vessel Percutaneous Coronary Intervention in Cardiogenic Shock	24
Apixaban and Valve Thrombosis After Transcatheter Aortic Valve Replacement	23
Appropriate Use of Intravascular Ultrasound During Arterial and Venous Lower Extremity Interventions	23
Quantitative Assessment of Acute Regurgitation Following TAVR	23
Use of Dual-Layered Stents for Carotid Artery Angioplasty	23
German Multicenter Experience With a New Leaflet-Based Transcatheter Mitral Valve Repair System for Mitral Regurgitation	23
Combined Pressure and Flow Measurements to Guide Treatment of Coronary Stenoses	23
Sex-Related Clinical Characteristics and Outcomes of Patients Undergoing Transcatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation	23
1-Year Outcomes of Cardioband Tricuspid Valve Reconstruction System Early Feasibility Study	23
Pharmacomechanical Catheter-Directed Thrombolysis With the Bashir Endovascular Catheter for Acute Pulmonary Embolism	23
Coronary Angiography in Patients With Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation	23
Role of Teleproctoring in Challenging and Innovative Structural Interventions Amid the COVID-19 Pandemic and Beyond	23
Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity	22
Early Experience With a Novel Transfemoral Mitral Valve Implantation System in Complex Degenerative Mitral Regurgitation	22
Predictors of Residual Right-to-Left Shunt After Percutaneous Suture-Mediated Patent Fossa Ovalis Closure	22
Cardiohepatic Syndrome Is Associated With Poor Prognosis in Patients Undergoing Tricuspid Transcatheter Edge-to-Edge Valve Repair	22
Operator Volumes and In-Hospital Outcomes	22
Association of Lipoprotein(a) With Recurrent Ischemic Events Following Percutaneous Coronary Intervention	22
Target Lesion Failure With Current Drug-Eluting Stents	22
Clinical Outcomes at 1 Year Following Transcatheter Left Atrial Appendage Occlusion in the United States	22
Evolution, Predictors, and Neurocognitive Effects of Silent Cerebral Embolism During Transcatheter Aortic Valve Replacement	22
Clinical Outcomes Following Isolated Transcatheter Tricuspid Valve Repair	22
Timing, Selection, Modulation, and Duration of P2Y12 Inhibitors for Patients With Acute Coronary Syndromes Undergoing PCI	22
Transcatheter Versus Rapid-Deployment Aortic Valve Replacement	22
Supraventricular Arrhythmia Following Patent Foramen Ovale Percutaneous Closure	22
Prognostic Implications of Post-Intervention Resting Pd/Pa and Fractional Flow Reserve in Patients With Stent Implantation	22
Subphenotyping of Patients With Aortic Stenosis by Unsupervised Agglomerative Clustering of Echocardiographic and Hemodynamic Data	22
Patient-Specific Computer Simulation in TAVR With the Self-Expanding Evolut R Valve	21
MIRACLE2 Score and SCAI Grade to Identify Patients With Out-of-Hospital Cardiac Arrest for Immediate Coronary Angiography	21
Coronary Access Following Redo TAVR	21
Same-Day Discharge Post–Transcatheter Aortic Valve Replacement During the COVID-19 Pandemic	21
Clinical Impact of Revascularization Extent in Patients Undergoing Impella-Protected PCI Enrolled in a Nationwide Registry	21
Potential Candidates for Transcatheter Tricuspid Valve Intervention After Transcatheter Aortic Valve Replacement	21
Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents	21
Antithrombotic Management of Elderly Patients With Coronary Artery Disease	21
Postoperative Atrial Fibrillation or Flutter Following Transcatheter or Surgical Aortic Valve Replacement	21
Patent Foramen Ovale Attributable Cryptogenic Embolism With Thrombophilia Has Higher Risk for Recurrence and Responds to Closure	21
P2Y12 Inhibitor or Aspirin Following Dual Antiplatelet Therapy After Percutaneous Coronary Intervention	21
Intracardiac Echocardiography to Guide Watchman FLX Implantation	21
Association of Acute Procedural Results With Long-Term Outcomes After CTO PCI	21
Effect of Sex Difference of Coronary Microvascular Dysfunction on Long-Term Outcomes in Deferred Lesions	20
Machine Learning Identifies Clinical Parameters to Predict Mortality in Patients Undergoing Transcatheter Mitral Valve Repair	20
Improving PCI Outcomes Using Postprocedural Physiology and Intravascular Imaging	20
Comparative Safety of Transcatheter LAAO With the First-Generation Watchman and Next-Generation Watchman FLX Devices	20
Left Ventricular Remodeling After Transcatheter Mitral Valve Replacement With Tendyne	20